Eva Chrenková
@evachrenkova.bsky.social
PhD student at Palacký University Olomouc and scientific coworker in Winkler Lab at MedUni Wien
Honored to receive the Dean’s Award from Palacký University’s Faculty of Medicine for my review on liquid biopsy in monitoring CRPC progression. Grateful for the recognition and support! See the article: www.frontiersin.org/journals/onc...
#ProstateCancer #LiquidBiopsy #PalackyUniversity
#ProstateCancer #LiquidBiopsy #PalackyUniversity
April 23, 2025 at 4:23 PM
Honored to receive the Dean’s Award from Palacký University’s Faculty of Medicine for my review on liquid biopsy in monitoring CRPC progression. Grateful for the recognition and support! See the article: www.frontiersin.org/journals/onc...
#ProstateCancer #LiquidBiopsy #PalackyUniversity
#ProstateCancer #LiquidBiopsy #PalackyUniversity
Reposted by Eva Chrenková
One week left to apply! Join my lab in beautiful Vienna for your #PhD studying #metastasis.
April 17, 2025 at 7:31 AM
One week left to apply! Join my lab in beautiful Vienna for your #PhD studying #metastasis.
Thrilled to share our latest study on predicting ARPI therapy failure in metastatic prostate cancer.
miR-375 & LMR predict ARPI failure in CRPC.
In mHSPC, platelets, CRP & CGA outperform PSA.
Toward personalized therapy—guided by blood.
#ProstateCancer #Oncology #Biomarkers #LiquidBiopsy
miR-375 & LMR predict ARPI failure in CRPC.
In mHSPC, platelets, CRP & CGA outperform PSA.
Toward personalized therapy—guided by blood.
#ProstateCancer #Oncology #Biomarkers #LiquidBiopsy
Platelets, Chromogranin A and C-Reactive Protein Predict Therapy Failure of Metastatic Hormone-Sensitive Prostate Cancer while miR-375 Outperforms Prostate-Specific Antigen in Stratifying Castration-R...
Androgen deprivation therapy has long been the first-line treatment for hormone-sensitive
prostate cancer (HSPC). After progression to castration-resistant prostate cancer
(CRPC), androgen receptor pa...
www.jmdjournal.org
April 7, 2025 at 5:48 PM
Thrilled to share our latest study on predicting ARPI therapy failure in metastatic prostate cancer.
miR-375 & LMR predict ARPI failure in CRPC.
In mHSPC, platelets, CRP & CGA outperform PSA.
Toward personalized therapy—guided by blood.
#ProstateCancer #Oncology #Biomarkers #LiquidBiopsy
miR-375 & LMR predict ARPI failure in CRPC.
In mHSPC, platelets, CRP & CGA outperform PSA.
Toward personalized therapy—guided by blood.
#ProstateCancer #Oncology #Biomarkers #LiquidBiopsy
Reposted by Eva Chrenková
🌟 Exciting #PhD Opportunity! Join my lab in beautiful #Vienna. We are studying tumor-immune interactions in #metastasis using #singlecell and #spatial omics! ⏰ Apply by 04/25 bit.ly/3l7WMhs more infos 👉 winklerlab.org
April 7, 2025 at 11:24 AM
🌟 Exciting #PhD Opportunity! Join my lab in beautiful #Vienna. We are studying tumor-immune interactions in #metastasis using #singlecell and #spatial omics! ⏰ Apply by 04/25 bit.ly/3l7WMhs more infos 👉 winklerlab.org
Grateful for the opportunity to contribute to prostate cancer research and for all the support along the way — especially from Jan Bouchal and his team at Department of Clinical and Molecular Pathology, Palacký University Olomouc. One step closer to the defense. #ThesisSubmitted#CancerResearch
April 1, 2025 at 8:57 PM
Grateful for the opportunity to contribute to prostate cancer research and for all the support along the way — especially from Jan Bouchal and his team at Department of Clinical and Molecular Pathology, Palacký University Olomouc. One step closer to the defense. #ThesisSubmitted#CancerResearch